Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Rev. patol. trop ; 51(1): 31-50, 2022. ilus, tab
Article in English | LILACS | ID: biblio-1411448

ABSTRACT

Tungiasis is a neglected parasitic disease caused by penetration of female Tunga penetrans under the skin, causing important health outcomes in humans. Therefore, the aim of this study was to describe the prevalence of tungiasis in Brazil and in its federative units. In November 2019, an investigation was carried out to find studies published from 1980 onwards in MEDLINE, LILACS, Cochrane, CINAHL, Scopus, Web of Science and Embase databases, and in the gray literature, using descriptors related to the prevalence of tungiasis caused by T. penetrans in Brazil. Of the 542 studies found, only 16 published between 2002 and 2010 met the eligibility criteria to be included in this systematic review. Of the 16 selected publications, 14 addressed the prevalence of tungiasis in communities in the Northeast region of the country, one in the South and one in the Southeast. The general prevalence of the parasitosis in the studies ranged from 1.6% to 54.8%, predominantly in the five to nine age group. Eight studies considered the prevalence by gender, ranging from 2.2% to 62.2% for females and 1.1% to 62.5% for males. This systematic review presents an unprecedented survey of the prevalence of tungiasis, a parasitic disease whose dissemination is facilitated by several factors, occuring mainly in low-income communities. Considering the regionalization of the findings, the scarcity of publications, as well as disease neglect, more studies are required.


Subject(s)
Humans , Parasitic Diseases , Skin , Tunga , Tungiasis
2.
Arq. bras. endocrinol. metab ; 52(4): 677-683, jun. 2008. ilus, tab
Article in Portuguese | LILACS | ID: lil-485834

ABSTRACT

O objetivo deste estudo foi verificar se o hipertireoidismo potencializa a osteopenia causada pela lactação. Foram utilizadas 24 ratas adultas distribuídas em quatro grupos: eutireóideo não lactante (controle), eutireóideo lactante, hipertireóideo não-lactante e hipertireóideo lactante. Todos os animais foram necropsiados, 20 dias após a gestação. As vértebras torácicas e lombares, o fêmur e a tíbia foram colhidos, descalcificados e submetidos à análise histomorfométrica. O grupo eutireóideo lactante apresentou osteopenia intensa em todos os sítios ósseos estudados. No grupo hipertireóideo não-lactante, não houve alteração da porcentagem de tecido ósseo trabecular nos sítios analisados. No grupo hipertireóideo lactante, havia osteopenia na tíbia e no fêmur, semelhante à do grupo eutireóideo lactante. Mas a porcentagem de tecido ósseo trabecular em todos os corpos vertebrais foi significativamente maior em comparação ao grupo eutireóideo lactante. Conclui-se que o hipertireoidismo não agrava a osteopenia lactacional em ratas, mas minimiza a osteopenia vertebral por estimular a atividade osteoblástica.


The objective of this study was to verify if hyperthyroidism potentiates the osteopenia lactational. 24 adult female rats were distributed in four groups: euthyroid no lactating (control), euthyroid lactating, hyperthyroid no lactating and hyperthyroid lactating. 20 days after gestation, all the animals were necropsied. The thoracic and lumbar vertebrae, the femur and tibia were decalcified and processed for histomorphometric analysis. The euthyroid lactating group presented intense osteopenia in the studied bones. In the hyperthyroid no lactating group, there was not any change in trabecular bone percentage in none of the analyzed bone. In the hyperthyroid lactating group, there was osteopenia in the tibia and femur, similar to the one in the euthyroid lactating group. But the trabecular bone percentage in all the vertebral bodies was significantly larger in comparison with the euthyroid lactating group. It was concluded that the hyperthyroidism does not potentiate the osteopenia lactational in female rats, but it minimizes the vertebral osteopenia once it stimulates the osteoblastic activity.


Subject(s)
Animals , Female , Rats , Bone Diseases, Metabolic/etiology , Hyperthyroidism/complications , Lactation , Bone Diseases, Metabolic/drug therapy , Bone Diseases, Metabolic/pathology , Rats, Wistar , Risk Factors , Thyroxine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL